"Pleural Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
Descriptor ID |
D010997
|
MeSH Number(s) |
C04.588.894.797.640 C08.528.694 C08.785.640
|
Concept/Terms |
Pleural Neoplasms- Pleural Neoplasms
- Neoplasms, Pleural
- Neoplasm, Pleural
- Pleural Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Pleural Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pleural Neoplasms".
This graph shows the total number of publications written about "Pleural Neoplasms" by people in this website by year, and whether "Pleural Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 |
1998 | 3 | 0 | 3 |
1999 | 2 | 0 | 2 |
2000 | 1 | 0 | 1 |
2002 | 2 | 0 | 2 |
2003 | 2 | 0 | 2 |
2004 | 4 | 0 | 4 |
2005 | 5 | 1 | 6 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2008 | 7 | 0 | 7 |
2009 | 3 | 0 | 3 |
2010 | 5 | 1 | 6 |
2011 | 6 | 1 | 7 |
2012 | 10 | 0 | 10 |
2013 | 5 | 1 | 6 |
2014 | 3 | 0 | 3 |
2015 | 6 | 0 | 6 |
2016 | 11 | 0 | 11 |
2017 | 1 | 0 | 1 |
2018 | 11 | 0 | 11 |
2019 | 9 | 2 | 11 |
2020 | 2 | 0 | 2 |
2021 | 4 | 0 | 4 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pleural Neoplasms" by people in Profiles.
-
Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group. J Thorac Oncol. 2023 03; 18(3):278-298.
-
Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2022 02; 164:76-83.
-
Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis. Am J Clin Pathol. 2021 Nov 08; 156(6):989-999.
-
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2021 10; 22(10):1438-1447.
-
Understanding the new therapeutic options for mesothelioma. Lancet Oncol. 2021 10; 22(10):1353-1355.
-
Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901. Clin Lung Cancer. 2020 11; 21(6):553-561.e1.
-
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study. Thorac Cancer. 2020 06; 11(6):1661-1669.
-
Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study. Lung Cancer. 2019 12; 138:139-140.
-
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 2020 01; 15(1):29-49.
-
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019 10; 14(10):1718-1731.